Viewing Study NCT02208167


Ignite Creation Date: 2025-12-25 @ 12:28 AM
Ignite Modification Date: 2026-02-22 @ 5:24 PM
Study NCT ID: NCT02208167
Status: COMPLETED
Last Update Posted: 2019-10-07
First Post: 2014-07-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Study of HIV 1 Antigen Expanded Specific T Cell Therapy
Sponsor: University of North Carolina, Chapel Hill
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 14-0741
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None UNKNOWN View
None NIH View
None NIH View